175 related articles for article (PubMed ID: 24040057)
1. Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters.
Bailey K; Kirk A; Naik S; Nace R; Steele MB; Suksanpaisan L; Li X; Federspiel MJ; Peng KW; Kirk D; Russell SJ
PLoS One; 2013; 8(9):e73759. PubMed ID: 24040057
[TBL] [Abstract][Full Text] [Related]
2. Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses.
Miller A; Nace R; Ayala-Breton C C; Steele M; Bailey K; Peng KW; Russell SJ
Mol Ther; 2016 Feb; 24(2):306-317. PubMed ID: 26647825
[TBL] [Abstract][Full Text] [Related]
3. Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis.
Gebremeskel S; Nelson A; Walker B; Oliphant T; Lobert L; Mahoney D; Johnston B
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33722907
[TBL] [Abstract][Full Text] [Related]
4. Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread.
Ayala-Breton C; Suksanpaisan L; Mader EK; Russell SJ; Peng KW
Mol Ther; 2013 Oct; 21(10):1930-7. PubMed ID: 23842448
[TBL] [Abstract][Full Text] [Related]
5. Curative one-shot systemic virotherapy in murine myeloma.
Naik S; Nace R; Federspiel MJ; Barber GN; Peng KW; Russell SJ
Leukemia; 2012 Aug; 26(8):1870-8. PubMed ID: 22425894
[TBL] [Abstract][Full Text] [Related]
6. Virus specific tolerance enhanced efficacy of cancer immuno-virotherapy.
Sobhanimonfared F; Bamdad T; Sadigh ZA; Choobin H
Microb Pathog; 2020 Mar; 140():103957. PubMed ID: 31891795
[TBL] [Abstract][Full Text] [Related]
7. Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.
Marchica V; Franceschi V; Vescovini R; Storti P; Vicario E; Toscani D; Zorzoli A; Airoldi I; Dalla Palma B; Campanini N; Martella E; Mancini C; Costa F; Donofrio G; Giuliani N
J Hematol Oncol; 2020 Jul; 13(1):89. PubMed ID: 32653014
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virotherapy for multiple myeloma.
Stief AE; McCart JA
Expert Opin Biol Ther; 2008 Apr; 8(4):463-73. PubMed ID: 18352850
[TBL] [Abstract][Full Text] [Related]
9. An HSV-2 based oncolytic virus can function as an attractant to guide migration of adoptively transferred T cells to tumor sites.
Fu X; Rivera A; Tao L; Zhang X
Oncotarget; 2015 Jan; 6(2):902-14. PubMed ID: 25460506
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.
Peng KW; Dogan A; Vrana J; Liu C; Ong HT; Kumar S; Dispenzieri A; Dietz AB; Russell SJ
Am J Hematol; 2009 Jul; 84(7):401-7. PubMed ID: 19507209
[TBL] [Abstract][Full Text] [Related]
11. Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.
Lemay CG; Rintoul JL; Kus A; Paterson JM; Garcia V; Falls TJ; Ferreira L; Bridle BW; Conrad DP; Tang VA; Diallo JS; Arulanandam R; Le Boeuf F; Garson K; Vanderhyden BC; Stojdl DF; Lichty BD; Atkins HL; Parato KA; Bell JC; Auer RC
Mol Ther; 2012 Sep; 20(9):1791-9. PubMed ID: 22760544
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.
Dingli D; Offord C; Myers R; Peng KW; Carr TW; Josic K; Russell SJ; Bajzer Z
Cancer Gene Ther; 2009 Dec; 16(12):873-82. PubMed ID: 19498461
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
[TBL] [Abstract][Full Text] [Related]
16. Converting tumor-specific markers into reporters of oncolytic virus infection.
Iankov ID; Hillestad ML; Dietz AB; Russell SJ; Galanis E
Mol Ther; 2009 Aug; 17(8):1395-403. PubMed ID: 19471250
[TBL] [Abstract][Full Text] [Related]
17. Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer.
Martin NT; Roy DG; Workenhe ST; van den Wollenberg DJM; Hoeben RC; Mossman KL; Bell JC; Bourgeois-Daigneault MC
Sci Rep; 2019 Feb; 9(1):1865. PubMed ID: 30755678
[TBL] [Abstract][Full Text] [Related]
18. Infection and killing of multiple myeloma by adenoviruses.
Senac JS; Doronin K; Russell SJ; Jelinek DF; Greipp PR; Barry MA
Hum Gene Ther; 2010 Feb; 21(2):179-90. PubMed ID: 19788385
[TBL] [Abstract][Full Text] [Related]
19. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.
Naik S; Nace R; Barber GN; Russell SJ
Cancer Gene Ther; 2012 Jul; 19(7):443-50. PubMed ID: 22522623
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
Ruiz AJ; Hadac EM; Nace RA; Russell SJ
J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
